Crossject
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Feb 1 to 28, 2027 · next Feb 1
- 1 fee due Apr 29, 2027The maintenance fee for Pharmaceutical hydrocortisone solution for an injection device (US 10,456,355) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Holding device for injection device tubes (US 11,911,589) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Method for air quenching an elongated glass hollow body comprising an axial bore (US 11,939,254) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,981,075 | Device for needleless injection operating with two concentric energetic materials In force · From the USPTO record | In force | From the USPTO record | |
| US 7,798,989 | Needleless syringe provided with a damping injector receptacle In force · From the USPTO record | In force | From the USPTO record | |
| US 8,197,440 | Needleless injection device with double stopper with low pressure profiles In force · From the USPTO record | In force | From the USPTO record | |
| US 8,784,371 | Needleless injection device equipped with a protected reservoir In force · From the USPTO record | In force | From the USPTO record | |
| US 10,675,409 | Needleless injection device with an improved sealing gasket In force · From the USPTO record | In force | From the USPTO record | |
| US 10,799,638 | Needleless injection device with an angularly-positionable closure stopper In force · From the USPTO record | In force | From the USPTO record | |
| US 10,835,679 | Needleless injection device equipped with an improved percussion device In force · From the USPTO record | In force | From the USPTO record | |
| US 10,653,839 | Needleless injection device with sliding membrane In force · From the USPTO record | In force | From the USPTO record | |
| US 11,712,521 | Injection Nozzle for a Needleless Injection Device In force · High confidence | In force | High confidence | |
| US 10,456,355 | Pharmaceutical hydrocortisone solution for an injection device In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 20: 3 lapsed for an unpaid fee · 45 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 no status recorded